Panacea Biotec Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹165.19 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.05 per cent from ₹141.13 crore. This corresponds to a year-on-year *(YoY) growth of 1.04 per cent.
Operating Profit
Operating Profit stands at ₹11.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 165.99 per cent from ₹-17.79 crore. This corresponds to a year-on-year *(YoY) growth of 47.49 per cent.
PBDT
PBDT stands at ₹14.94 crore, reflecting a quarter-on-quarter *(QoQ) increase of 237.95 per cent from ₹-10.83 crore. This corresponds to a year-on-year *(YoY) growth of 11.83 per cent.
Profit Before Tax
Profit Before Tax stands at ₹6.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 133.85 per cent from ₹-19.17 crore. This corresponds to a year-on-year *(YoY) growth of 48.17 per cent.
Net Profit
Net Profit stands at ₹3.89 crore, reflecting a quarter-on-quarter *(QoQ) increase of 127.77 per cent from ₹-14.01 crore. This represents a 12.39 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Panacea Biotec Ltd Earnings
- YOY
- QOQ
Panacea Biotec Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Panacea Biotec Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Panacea Biotec Ltd Financial Reports
Panacea Biotec Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Panacea Biotec | -1.79% | -4.20% | 12.15% | -2.20% | -12.77% | -30.49% |
| Novartis India | -0.12% | -1.90% | 3.28% | 25.28% | 24.24% | 31.45% |
| Hikal | 0.29% | 1.20% | 16.37% | -0.63% | -18.40% | -52.27% |
| Morepen Labs. | -0.96% | -2.06% | 7.70% | 9.20% | -11.95% | -32.15% |
| Sai Parenteral's | 0.08% | 0.51% | 19.80% | 19.69% | 19.69% | 19.69% |
| Titan Biotech | 4.54% | 9.59% | -6.27% | 139.69% | 149.94% | 437.67% |
| Indoco Remedies | -0.05% | -0.83% | 10.47% | -6.61% | -19.44% | -11.66% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Rajesh Jain
ED / Joint MD / Promoter : Sandeep Jain
WTD & Executive Director : Ankesh Jain
WTD & Executive Director : Harshet Jain
Executive Director / WTD - Technical : Sanjay Trehan
Independent Non Exe. Director : Ambika Sharma
Independent Non Exe. Director : Krishan Kumar Jalan
Independent Non Exe. Director : Rajesh Jain
Independent Non Exe. Director : Rajender Pal Singh
Independent Non Exe. Director : Venkatesh Sarvasiddhi
CS / Compliance Officer / Group CFO / Head - Legal : Vinod Goel